Maintenance of platelet inhibition during antiplatelet therapy
US10022391B2 · kind B2 · utility
240Cited by
15References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2016 |
| Grant date | Jul 17, 2018 |
| Priority date | — |
| Expiry date | Apr 24, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.